Literature DB >> 22660550

Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis.

Giuseppe Vezzoli1, Annalisa Terranegra, Laura Soldati.   

Abstract

PURPOSE OF REVIEW: The calcium-sensing receptor gene (CaSR, chr. 3q13.3-21) is a candidate to explain nephrolithiasis. This review analyzes the potential role of CaSR in lithogenesis according to findings of functional and genetic studies. RECENT
FINDINGS: CaSR is a cation receptor located in the tubular cell plasma membrane. Its activation decreases calcium reabsorption in the ascending limb and distal convoluted tubule, but increases phosphate reabsorption in proximal tubules and decreases water and proton reabsorption in collecting ducts. Its effects in proximal tubules and collecting ducts can limit the calcium phosphate precipitation risk induced by the increase in calcium excretion. The nonconservative CaSR gene Arg990Gly polymorphism was associated with nephrolithiasis and hypercalciuria in different populations. Arg990Gly is located on exon 7 and produces a gain of the CaSR function. rs7652589 and rs1501899 were also associated with nephrolithiasis in patients with normal citrate excretion. These polymorphisms are located in the CaSR gene regulatory region and may modify CaSR gene promoter activity.
SUMMARY: The activating Arg990Gly polymorphism may predispose to nephrolithiasis by increasing calcium excretion. Polymorphisms at the regulatory region may predispose to nephrolithiasis by changing tubular expression of the CaSR. CaSR genotype may be a marker to identify patients prone to develop calcium nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22660550     DOI: 10.1097/MNH.0b013e3283542290

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  18 in total

Review 1.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

Review 3.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

4.  Claudin-14 Gene Polymorphisms and Urine Calcium Excretion.

Authors:  Teresa Arcidiacono; Marco Simonini; Chiara Lanzani; Lorena Citterio; Erika Salvi; Cristina Barlassina; Donatella Spotti; Daniele Cusi; Paolo Manunta; Giuseppe Vezzoli
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-19       Impact factor: 8.237

Review 5.  Inherited proximal tubular disorders and nephrolithiasis.

Authors:  Ben Oliveira; Robert Unwin; Stephen B Walsh
Journal:  Urolithiasis       Date:  2019-01-23       Impact factor: 3.436

Review 6.  Localization and function of the renal calcium-sensing receptor.

Authors:  Daniela Riccardi; Giovanna Valenti
Journal:  Nat Rev Nephrol       Date:  2016-05-09       Impact factor: 28.314

Review 7.  Genetics of common complex kidney stone disease: insights from genome-wide association studies.

Authors:  Runolfur Palsson; Olafur S Indridason; Vidar O Edvardsson; Asmundur Oddsson
Journal:  Urolithiasis       Date:  2018-12-06       Impact factor: 3.436

Review 8.  Current opinions on nephrolithiasis associated with primary hyperparathyroidism.

Authors:  Xiaoming Cong; Luming Shen; Xiaojian Gu
Journal:  Urolithiasis       Date:  2018-01-19       Impact factor: 3.436

Review 9.  Calcium-sensing receptor: evidence and hypothesis for its role in nephrolithiasis.

Authors:  Giuseppe Vezzoli; Lorenza Macrina; Giulia Magni; Teresa Arcidiacono
Journal:  Urolithiasis       Date:  2018-11-16       Impact factor: 3.436

10.  Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene.

Authors:  Giuseppe Vezzoli; Alfredo Scillitani; Sabrina Corbetta; Annalisa Terranegra; Elena Dogliotti; Vito Guarnieri; Teresa Arcidiacono; Lorenza Macrina; Alessandra Mingione; Caterina Brasacchio; Cristina Eller-Vainicher; Daniele Cusi; Anna Spada; David E C Cole; Geoffrey N Hendy; Donatella Spotti; Laura Soldati
Journal:  J Nephrol       Date:  2014-05-16       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.